{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:11:21Z","timestamp":1779376281466,"version":"3.53.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T00:00:00Z","timestamp":1582502400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T00:00:00Z","timestamp":1582502400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Measurement of sputum is frequently used to define airway inflammatory subtypes. The venous blood cell is a reliable and simple biomarker, may be used as an alternative procedure to reflect the subtypes. For the aim of verifying the hypothesis that venous blood cell can quantify sputum inflammatory cell to access the airway subtypes in chronic obstructive pulmonary disease of acute exacerbations (AECOPD) and to ascertain the accuracy of the blood cell biomarker.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study evaluated 287 patients with COPD exacerbations and all four tests were performed on the same day, which are lung function test, bronchodilator reversibility test, sputum cell analysis and blood routine examination.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>There was a correlation between sputum eosinophils and blood eosinophils, blood cells derived ratios. There was a weaker relationship to neutrophils between sputum and blood. Sputum neutrophils had not any association with neutrophil\/macrophage ratio (NMR) and eosinophil\/lymphocyte ratio (ELR) in blood. Blood eosinophils percentage was predictive for eosinophilic COPD exacerbations with an area under the curve (AUC) of 0.672 (<jats:italic>p<\/jats:italic>\u2009=\u20090.012). The optimum cutpoint for blood eosinophils percentage was 0.55%. Blood eosinophils absolute count was also predictive sputum eosinophilia at 0.35\u2009\u00d7\u200910<jats:sup>9<\/jats:sup>\/L (AUC\u2009=\u20090.626, <jats:italic>p<\/jats:italic>\u2009=\u20090.025). ELR, eosinophil\/monocyte ratio (EMR) and eosinophil\/neutrophil ratio (ENR) in blood were higher in COPD exacerbations with mixed granulocytic and eosinophilic subtypes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Eosinophils\/neutrophils count parameters were relationship between blood and sputum. Eosinophils in blood and the ratios (ENR, EMR and ELR) may be utilized to assess eosinophilic airway inflammation in COPD exacerbations. Due to weak relationship and poor predictive ability, more researches should be required.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12890-020-1086-1","type":"journal-article","created":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T16:09:09Z","timestamp":1582560549000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Blood cell for the differentiation of airway inflammatory phenotypes in COPD exacerbations"],"prefix":"10.1186","volume":"20","author":[{"given":"Jie","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bida","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sifang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6911-4896","authenticated-orcid":false,"given":"Feng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,24]]},"reference":[{"key":"1086_CR1","unstructured":"The Global Strategy for the Diagnosis, Management and Prevention of COPD [webpage on the Internet]. Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2018. Available from: http:\/\/www.goldcopd.org\/. Accessed October 16, 2018."},{"issue":"9589","key":"1086_CR2","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S0140-6736(07)61382-8","volume":"370","author":"JA Wedzicha","year":"2007","unstructured":"Wedzicha JA, Seemungal TA. COPD exacerbations: defining their cause and prevention. Lancet. 2007;370(9589):786\u201396.","journal-title":"Lancet"},{"issue":"5","key":"1086_CR3","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1164\/ajrccm.157.5.9709032","volume":"157","author":"TA Seemungal","year":"1998","unstructured":"Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(5):1418\u201322.","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"1086_CR4","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/S2213-2600(14)70187-0","volume":"2","author":"CE Brightling","year":"2014","unstructured":"Brightling CE, Bleecker ER, Panettieri RA Jr, Bafadhel M, She D, Ward CK, et al. Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study. Lancet Respir Med. 2014;2(11):891\u2013901.","journal-title":"Lancet Respir Med"},{"key":"1086_CR5","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/1471-2466-14-112","volume":"14","author":"O Eltboli","year":"2014","unstructured":"Eltboli O, Bafadhel M, Hollins F, Wright A, Hargadon B, Kulkarni N, et al. COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils. BMC Pulm Med. 2014;14:112.","journal-title":"BMC Pulm Med"},{"issue":"5 Pt 1","key":"1086_CR6","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1164\/ajrccm.158.5.9804028","volume":"158","author":"E Pizzichini","year":"1998","unstructured":"Pizzichini E, Pizzichini MM, Gibson P, Gleich JG, Berman L, Dolovich J, et al. Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis. Am J Respir Crit Care Med. 1998;158(5 Pt 1):1511\u20137.","journal-title":"Am J Respir Crit Care Med"},{"issue":"9240","key":"1086_CR7","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/S0140-6736(00)02872-5","volume":"356","author":"CE Brightling","year":"2000","unstructured":"Brightling CE, Monteiro W, Ward R, Parker D, Morgan DM, Pavord DI. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet. 2000;356(9240):1480\u20135.","journal-title":"Lancet"},{"issue":"3","key":"1086_CR8","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/00001648-200005000-00006","volume":"11","author":"JJ Hospers","year":"2000","unstructured":"Hospers JJ, Schouten JP, Weiss ST, Postma DS, Rijcken B. Eosinophilia is associated with increased all-cause mortality after a follow-up of 30 years in a general population sample. Epidemiology. 2000;11(3):261\u20138.","journal-title":"Epidemiology."},{"issue":"1","key":"1086_CR9","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1440-1843.2006.00784.x","volume":"11","author":"JL Simpson","year":"2006","unstructured":"Simpson JL, Scott R, Boyle MJ, Gibson PG. Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology. 2006;11(1):54\u201361.","journal-title":"Respirology."},{"issue":"11","key":"1086_CR10","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.2147\/COPD.S100338","volume":"1","author":"NA Negewo","year":"2016","unstructured":"Negewo NA, McDonald VM, Baines KJ, Wark PA, Simpson JL, Jones PW, et al. Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD. Int J Chron Obstruct Pulmon Dis. 2016;1(11):1495\u2013504.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"12","key":"1086_CR11","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.2147\/COPD.S134998","volume":"4","author":"J Gao","year":"2017","unstructured":"Gao J, Zhang M, Zhou LQ, Yang X, Wu HG, Zhang JF, et al. Correlation between fractional exhaled nitric oxide and sputum eosinophilia in exacerbations of COPD. Int J Chron Obstruct Pulmon Dis. 2017;4(12):1287\u201393.","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"issue":"8","key":"1086_CR12","first-page":"566","volume":"37","author":"Pulmonary Function Workgroup of Chinese Society of Respiratory Diseases (CSRD), Chinese Medical Association","year":"2014","unstructured":"Pulmonary Function Workgroup of Chinese Society of Respiratory Diseases (CSRD), Chinese Medical Association. The Chinese national guidelines of pulmonary function test (2014). Chin J Tuberc Respir Dis. 2014;37(8):566\u201371.","journal-title":"Chin J Tuberc Respir Dis"},{"key":"1086_CR13","first-page":"321","volume":"39","author":"Asthma Workgroup of Chinese Society of Respiratory Diseases (CSRD), Chinese Medical Association","year":"2016","unstructured":"Asthma Workgroup of Chinese Society of Respiratory Diseases (CSRD), Chinese Medical Association. The Chinese national guidelines on diagnosis and management of cough (2015). Chin J Tuberc Respir Dis. 2016;39:321\u201339.","journal-title":"Chin J Tuberc Respir Dis"},{"key":"1086_CR14","first-page":"57","volume":"125","author":"J Gao","year":"2019","unstructured":"Gao J, Wu SF, Lin WM, Zhou LQ, Wu F. Blood cells for the differentiation of AECOPD airway inflammatory phenotypes. Basic Clin Pharmacol Toxicol. 2019;125:57\u20138.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"6","key":"1086_CR15","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1183\/09031936.05.00055705","volume":"26","author":"M Woodhead","year":"2005","unstructured":"Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, et al. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J. 2005;26(6):1138\u201380.","journal-title":"Eur Respir J"},{"issue":"10","key":"1086_CR16","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1164\/rccm.200506-859OC","volume":"173","author":"A Papi","year":"2006","unstructured":"Papi A, Bellettato CM, Braccioni F, Romagnoli M, Casolari P, Caramori C, et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med. 2006;173(10):1114\u201321.","journal-title":"Am J Respir Crit Care Med"},{"key":"1086_CR17","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1056\/NEJMra0800353","volume":"359","author":"S Sethi","year":"2008","unstructured":"Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med. 2008;359:2355\u201365.","journal-title":"N Engl J Med"},{"issue":"1","key":"1086_CR18","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12931-015-0250-2","volume":"16","author":"ED Bateman","year":"2015","unstructured":"Bateman ED, Chapman KR, Singh D, D'Urzo AD, Molins E, Leselbaum A, et al. Aclidinium bromide and formoterol fumarate as a fixeddose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multicentre, randomised studies (ACLIFORM and AUGMENT). Respir Res. 2015;16(1):92.","journal-title":"Respir Res"},{"issue":"6","key":"1086_CR19","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1164\/rccm.201104-0597OC","volume":"184","author":"M Bafadhel","year":"2011","unstructured":"Bafadhel M, McKenna S, Terry S, Mistry V, Reid C, Haldar P, et al. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med. 2011;184(6):662\u201371.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"1086_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(15)00258-1","volume":"3","author":"L Groenke","year":"2015","unstructured":"Groenke L, Disse B. Blood eosinophil counts as markers of response to inhaled corticosteroids in COPD? Lancet Respir Med. 2015;3(8):e26.","journal-title":"Lancet Respir Med"},{"issue":"1","key":"1086_CR21","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1164\/rccm.201108-1553OC","volume":"186","author":"M Bafadhel","year":"2012","unstructured":"Bafadhel M, McKenna S, Terry S, Mistry V, Pancholi M, Venge P, et al. Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial. Am J Respir Crit Care Med. 2012;186(1):48\u201355.","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"1086_CR22","doi-asserted-by":"publisher","first-page":"717","DOI":"10.2169\/internalmedicine.51.6834","volume":"51","author":"ZL Liang","year":"2012","unstructured":"Liang ZL, Zhao HJ, Lv YH, Li R, Dong HM, Liu LY, et al. Moderate accuracy of peripheral eosinophil count for predicting Eosinophilic phenotype in steroid-Na\u00efve non-atopic adult asthmatics. Intern Med. 2012;51(7):717\u201322.","journal-title":"Intern Med"},{"issue":"5","key":"1086_CR23","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1007\/s10753-013-9653-8","volume":"36","author":"S Soter","year":"2013","unstructured":"Soter S, Barta I, Antus B. Predicting sputum eosinophilia in exacerbations of COPD using exhaled nitric oxide. Inflammation. 2013;36(5):1178\u201385.","journal-title":"Inflammation"},{"issue":"12","key":"1086_CR24","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S2213-2600(17)30432-0","volume":"5","author":"AT Hastie","year":"2017","unstructured":"Hastie AT, Martinez FJ, Curtis JL. Sputum or blood eosinophil association with clinical measures of COPD severity in the SPIROMICS cohort. Lancet Respir Med. 2017;5(12):956\u201367.","journal-title":"Lancet Respir Med"},{"issue":"4","key":"1086_CR25","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1164\/rccm.201502-0235LE","volume":"192","author":"SH Siddiqui","year":"2015","unstructured":"Siddiqui SH, Guasconi A, Vestbo J, Jones P, Agusti A, Paggiaro P, et al. Blood eosinophils: a biomarker of response to extrafine becomethasone\/formoterol in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;192(4):523\u20135.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"1086_CR26","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/S2213-2600(16)00100-4","volume":"4","author":"H Watz","year":"2016","unstructured":"Watz H, Tetzlaff K, Wouters EFM, Kirsten A, Magnussen H, Rodriguez-Roisin R, et al. Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial. Lancet Respir Med. 2016;4(5):390\u20138.","journal-title":"Lancet Respir Med"},{"issue":"11","key":"1086_CR27","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/resp.13312","volume":"23","author":"FJ Hartjes","year":"2018","unstructured":"Hartjes FJ, Vonk JM, Faiz A, Hiemstra PS, Lapperre TS, Kerstjens HAM, et al. Predictive value of eosinophils and neutrophils on clinical effects of ICS in COPD. Respirology. 2018;23(11):1023\u201331.","journal-title":"Respirology"},{"issue":"1","key":"1086_CR28","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jaci.2013.03.044","volume":"132","author":"AT Hastie","year":"2013","unstructured":"Hastie AT, Moore WC, Li H, Rector BM, Ortega VE, Pascual RM, et al. Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthmatic subjects. J Allergy Clin Immunol. 2013;132(1):72\u201380.","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"1086_CR29","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1111\/cea.12345","volume":"44","author":"XY Zhang","year":"2014","unstructured":"Zhang XY, Simpson JL, Powell H, Yang IA, Upham JW, Reynolds PN, et al. Full blood count parameters for the detection of asthma inflammatory phenotypes. Clin Exp Allergy. 2014;44(9):1137\u201345.","journal-title":"Clin Exp Allergy"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-020-1086-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12890-020-1086-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-020-1086-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T00:10:51Z","timestamp":1614039051000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-020-1086-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,24]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1086"],"URL":"https:\/\/doi.org\/10.1186\/s12890-020-1086-1","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,24]]},"assertion":[{"value":"16 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Institutional Review Board of Huizhou the third people\u2019s Hospital, which absolved the need for written informed consent because of the retrospective study. All personal identification data were anonymized and de-identified before analysis.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"50"}}